Vertex Pharmaceuticals (VRTX)

Financing Cash Flow

-$426.70M

Quarterly · Period ending: · USD

VRTX logo

VRTX Financing Cash Flow

Latest reported-$426.70M
VRTX Quarterly Cash from Financing ($26.00M → -$426.70M)
High-resolution chart · PNG

VRTX financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-426,700,000
-538,800,000
-77,200,000
-1,154,500,000
-349,200,000
-680,400,000
-391,300,000
-387,500,000
-358,600,000
-357,500,000
-119,800,000
-165,000,000
17,300,000
-294,700,000
40,200,000
-60,200,000
47,700,000
-95,400,000
-336,235,000
-656,661,000
33,550,000
-518,654,000
-125,192,000
-140,684,000
120,025,000
-359,430,000
161,421,000
20,356,000
-13,015,000
-41,989,000
-101,046,000
2,079,000
-51,208,000
78,956,000
73,231,000
152,705,000
132,033,000
-289,565,000
93,762,000
13,554,000
21,253,000
4,702,000
97,797,000
34,619,000
21,144,000
35,359,000
56,322,000
357,233,000
33,405,000
50,416,000
16,525,000
13,006,000
157,488,000
-6,135,000
4,837,000
8,150,000
137,692,000
21,525,000
-182,980,000
20,069,000
55,030,000
-16,357,000
9,447,000
398,495,000
9,473,000
7,642,000
538,664,000
130,593,000
11,081,000
318,668,000
13,715,000
224,962,000
-9,918,000
391,979,000
10,727,000
-32,397,000
8,136,000
3,344,000
14,302,000
319,854,000
9,549,000
22,160,000
15,641,000
11,769,000
169,474,000
572,000
3,478,000
-1,094,000
-10,949,000
-61,000
16,680,000
8,974,000
804,000
11,010,000
6,648,000
833,000
4,778,000
1,583,000
-16,618,000
2,365,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.